MAALKDQLIV NLLKEEQVPQ NKITVVGVGA VGMACAISIL MKDLADELALVDVIEDKLKG EMMDLQHGSL FLKTPKIVSS KDYSVTANSK LVIITAGARQ QEGESRLNLV QRNVNIFKFIIPNVVKYSPQ CKLLIVSNPV DILTYVAWKI SGFPKNRVIG SGCNLDSARF RYLMGERLGV HPLSCHGWVLGEHGDSSVPV WSGVNVAGVS LKSLNPQLGT DADKEQWKDV HKQVVDSAYE VIKLKGYTSW AIGLSVADLAESIMKNLRRV HPISTMIKGL YGIKEDVFLS VPCILGQNGI SDVVKVTLTP DEEARLKKSA DTLWGIQKEL QFLEHHHHHH

MW previsto

37.5 kDa

Purezza

>95% as determined by SDS-PAGE.

Forma del prodotto

Liquid

Concentrazione

0.25 mg/ml

Formulazione

Supplied in Phosphate Buffered Saline, pH 7.4, with 1 mM DTT and 20% Glycerol.

Conservazione

Shipped at 4°C. Short term (2-4 weeks) store at 4°C. Long term store at -20°C, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid freeze/thaw cycles.

Sinonimi

Cell proliferation inducing gene 19 protein, Cell proliferation-inducing gene 19 protein, Epididymis secretory protein Li 281, Epididymis secretory sperm binding protein Li 133P, GSD11, HEL S 133P, HEL S 281, L lactate dehydrogenase A chain, L lactate dehydrogenase B chain, L-lactate dehydrogenase A chain, Lactate dehydrogenase A, Lactate dehydrogenase B, Lactate dehydrogenase H chain, Lactate dehydrogenase M, LDH A, LDH B, LDH H, LDH heart subunit, LDH M, LDH muscle subunit, LDH-A, LDH-M, LDH1, LDHA, LDHA_HUMAN, LDHB, LDHBD, LDHM, MS1111, PIG19, Proliferation inducing gene 19, Renal carcinoma antigen NY REN 46, Renal carcinoma antigen NY REN 59, Renal carcinoma antigen NY-REN-59, TRG 5, TRG5

Dichiarazione di non responsabilità

Questo prodotto è solo per uso di ricerca. Non è inteso per uso diagnostico o terapeutico.